therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-81563033-8344РостГМУ10.21886/2712-8156-2020-1-1-50-55therapeutic-8Research ArticleОБЗОРЫREVIEWSАОРТАЛЬНЫЙ СТЕНОЗ, ДИАГНОСТИКА, ТАКТИКА ЛЕЧЕНИЯ. ЧТО ВАЖНО ЗНАТЬ ТЕРАПЕВТУ?AORTIC STENOSIS, DIAGNOSIS, TREATMENT TACTICS. WHAT IS IMPORTANT FOR THE THERAPIST TO KNOW?https://orcid.org/0000-0003-0350-6843КрючковаО. Н.KryuchkovaO. N.
Dr. Sci. (Med.), Prof.
Simferopol
kryuchkova62@yandex.ruhttps://orcid.org/0000-0002-1427-5174ИцковаЕ. А.ItskovaE. A.
Simferopol
itskova@mail.ruhttps://orcid.org/0000-0003-1318-1069ЛутайЮ. А.LutaiYu. A.
Cand. Sci. (Med.), Associate Prof
Simferopol
25u@rambler.ruhttps://orcid.org/0000-0001-6446-2261ТурнаЭ. Ю.TurnaE. U.turna-e@yandex.ruhttps://orcid.org/0000-0003-3994-5784ЖуковаН. В.ZhukovaN. V.natalizhukova3@rambler.ruhttps://orcid.org/0000-0002-3311-2346КостюковаЕ. А.KostyukovaE. A.
Cand. Sci. (Med.), Associate Prof.,
Simferopol
elenakostyukova@rambler.ruФГАОУ ВО «Крымский федеральный университет им. В.И. Вернадского»РоссияV.I. Vernadsky Crimean Federal UniversityRussian Federation202017052020115055Copyright © Крючкова О.Н., Ицкова Е.А., Лутай Ю.А., Турна Э.Ю., Жукова Н.В., Костюкова Е.А., 20202020Крючкова О.Н., Ицкова Е.А., Лутай Ю.А., Турна Э.Ю., Жукова Н.В., Костюкова Е.А.Kryuchkova O.N., Itskova E.A., Lutai Y.A., Turna E.U., Zhukova N.V., Kostyukova E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/8клапанная болезнь сердцааортальный стеноздиагностикалечениеvalvular heart diseaseaortic stenosisdiagnosistreatmentReferencesBaumgartner H, Falk V, Bax JJ, Bonis MD, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur.Heart J. 2017;36(21):2739-2791. https://doi.org/10.1093/eurheartj/ehx391Baumgartner H, Falk V, Bax JJ, Bonis MD, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur.Heart J. 2017;36(21):2739-2791. https://doi.org/10.1093/eurheartj/ehx391Iung B., Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8:162–172. https://doi.org/10.1038/nrcardio.2010.202.Iung B., Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8:162–172. https://doi.org/10.1038/nrcardio.2010.202.Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart. 2013;99(6):396–400. https://doi.org/10.1136/heartjnl-2012-302265.Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart. 2013;99(6):396–400. https://doi.org/10.1136/heartjnl-2012-302265.Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. The Lancet. 2006;368(9540):1005–1011. https://doi.org/10.1016/S0140-6736(06)69208-8Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. The Lancet. 2006;368(9540):1005–1011. https://doi.org/10.1016/S0140-6736(06)69208-8Котовская Ю.В., Курашев Д.Х., Темненко Н.А., Гароян В.О. Стеноз аортального клапана у пациентов пожилого и старческого возраста. Российский медицинский журнал. 2017;25:1833-1836. eLIBRARY ID: 32426772Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56(4):278–287. https://doi.org/10.1016/j.jacc.2009.12.074Аортальный стеноз. Клинические рекомендации. Ассоциация сердечно-сосудистых хирургов России. Всероссийское научное общество кардиологов; 2016.Marechaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A, et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J. 2010;31(11):1390–1397. https://doi.org/10.1093/eurheartj/ehq076Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56(4):278–287. https://doi.org/10.1016/j.jacc.2009.12.074Clavel MA, Dumesnil JG, Capoulade R, Mathieu P, Senechal M, Pibarot P. Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1259–1267. https://doi.org/10.1016/j.jacc.2011.12.054Marechaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A, et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J. 2010;31(11):1390–1397. https://doi.org/10.1093/eurheartj/ehq076Tribouilloy C, Rusinaru D, Marechaux S, Castel AL, Debry N, Maizel J, et al. Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery. J Am Coll Cardiol. 2015;65:55–66. https://doi.org/10.1016/j.jacc.2014.09.080.Clavel MA, Dumesnil JG, Capoulade R, Mathieu P, Senechal M, Pibarot P. Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1259–1267. https://doi.org/10.1016/j.jacc.2011.12.054Rafique AM, Biner S, Ray I, Forrester JS, Tolstrup K, Siegel RJ. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am J Cardiol. 2009;104(7):972–977. https://doi.org/10.1016/j.amjcard.2009.05.044Tribouilloy C, Rusinaru D, Marechaux S, Castel AL, Debry N, Maizel J, et al. Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery. J Am Coll Cardiol. 2015;65:55–66. https://doi.org/10.1016/j.jacc.2014.09.080.Thourani VH, Suri RM, Gunter RL, Sheng S, O’Brien SM, Ailawadi G, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediaterisk, and high-risk patients. Ann Thorac Surg. 2015;99(1):55–61. https://doi.org/10.1016/j.athoracsur.2014.06.050Rafique AM, Biner S, Ray I, Forrester JS, Tolstrup K, Siegel RJ. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am J Cardiol. 2009;104(7):972–977. https://doi.org/10.1016/j.amjcard.2009.05.044Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. https://doi.org/10.1056/NEJMoa1008232.Thourani VH, Suri RM, Gunter RL, Sheng S, O’Brien SM, Ailawadi G, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediaterisk, and high-risk patients. Ann Thorac Surg. 2015;99(1):55–61. https://doi.org/10.1016/j.athoracsur.2014.06.050Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–2194. https://doi.org/10.1016/j.jacc.2015.03.014.Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. https://doi.org/10.1056/NEJMoa1008232.Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620. https://doi.org/10.1056/NEJMoa1514616.Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–2194. https://doi.org/10.1016/j.jacc.2015.03.014.Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016;37:3503–3512. https://doi.org/10.1093/eurheartj/ehw225.Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620. https://doi.org/10.1056/NEJMoa1514616.Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediaterisk patients. N Engl J Med. 2017;376:1321–1331. https://doi.org/10.1056/NEJMoa1700456.Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016;37:3503–3512. https://doi.org/10.1093/eurheartj/ehw225.Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108(3):319–324. https://doi.org/10.1161/01.CIR.0000079171.43055.46Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediaterisk patients. N Engl J Med. 2017;376:1321–1331. https://doi.org/10.1056/NEJMoa1700456.Clavel MA Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014;64(12):1202–1213. https://doi.org/10.1016/j.jacc.2014.05.066Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108(3):319–324. https://doi.org/10.1161/01.CIR.0000079171.43055.46Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM. Clinical Investigators. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–2574. https://doi.org/10.1016/j.jacc.2016.03.506.Clavel MA Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014;64(12):1202–1213. https://doi.org/10.1016/j.jacc.2014.05.066Adams DH, Popma JJ, Reardon MJ, Yakubov SJ. U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–1798. https://doi.org/10.1056/NEJMoa1400590.Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM. Clinical Investigators. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–2574. https://doi.org/10.1016/j.jacc.2016.03.506.Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–2225. https://doi.org/10.1016/S0140-6736(16)30073-3.Adams DH, Popma JJ, Reardon MJ, Yakubov SJ. U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–1798. https://doi.org/10.1056/NEJMoa1400590.Rogers T, Koifman E, Patel N, Gai J, Torguson R, Corso P, et al. Society of Thoracic Surgeons score variance results in risk reclassification of patients undergoing transcatheter aortic valve replacement. JAMA Cardiol. 2017;2:455–456. https://doi.org/10.1001/jamacardio.2016.4132.Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–2225. https://doi.org/10.1016/S0140-6736(16)30073-3.Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2020;41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455Rogers T, Koifman E, Patel N, Gai J, Torguson R, Corso P, et al. Society of Thoracic Surgeons score variance results in risk reclassification of patients undergoing transcatheter aortic valve replacement. JAMA Cardiol. 2017;2:455–456. https://doi.org/10.1001/jamacardio.2016.4132.Genereux P, Stone GW, O’Gara PT, Marquis-Gravel G, Redfors B, Giustino G, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2016;67:2263–2288. https://doi.org/10.1016/j.jacc.2016.02.057Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2020;41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455Dahl JS, Videbaek L, Poulsen MK, Rudbaek TR, Pellikka PA, Moller JE. Global strain in severe aortic valve stenosis: relation to clinical outcome after aortic valve replacement. Circ Cardiovasc Imaging. 2012;5:613–620. https://doi.org/10.1161/CIRCIMAGING.112.973834Genereux P, Stone GW, O’Gara PT, Marquis-Gravel G, Redfors B, Giustino G, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2016;67:2263–2288. https://doi.org/10.1016/j.jacc.2016.02.057Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–1356. https://doi.org/10.1056/NEJMoa0804602Dahl JS, Videbaek L, Poulsen MK, Rudbaek TR, Pellikka PA, Moller JE. Global strain in severe aortic valve stenosis: relation to clinical outcome after aortic valve replacement. Circ Cardiovasc Imaging. 2012;5:613–620. https://doi.org/10.1161/CIRCIMAGING.112.973834Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. https://doi.org/10.1093/eurheartj/ehw128.Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–1356. https://doi.org/10.1056/NEJMoa0804602Smith WT, Ferguson TB, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol. 2004;44:1241–1247. https://doi.org/10.1016/j.jacc.2004.06.031Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. https://doi.org/10.1093/eurheartj/ehw128.Hankey GJ, Patel MR, Stevens SR. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012;11(4):315–322. https://doi.org/10.1016/S1474-4422(12)70042-X.Smith WT, Ferguson TB, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol. 2004;44:1241–1247. https://doi.org/10.1016/j.jacc.2004.06.031Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D, et al. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: Observations from the ARISTOTLE trial. European Heart Journal. 2014;35(28):1864-72. https://doi.org/10.1093/eurheartj/ehu046Hankey GJ, Patel MR, Stevens SR. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012;11(4):315–322. https://doi.org/10.1016/S1474-4422(12)70042-X.Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, et al. Changes in renal function in patients with atrial fibrillation: an analysis from the RELY trial. J. Am. Coll. Cardiol. 2015;65(23):2481–2493. https://doi.org/10.1016/j.jacc.2015.03.577Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D, et al. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: Observations from the ARISTOTLE trial. European Heart Journal. 2014;35(28):1864-72. https://doi.org/10.1093/eurheartj/ehu046Ye J, Cheung A, Yamashita M, Wood D, Peng D. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC Cardiovasc Interv. 2015;8:1735–1744. https://doi.org/10.1016/j.jcin.2015.08.012Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, et al. Changes in renal function in patients with atrial fibrillation: an analysis from the RELY trial. J. Am. Coll. Cardiol. 2015;65(23):2481–2493. https://doi.org/10.1016/j.jacc.2015.03.577Butchart EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, et al. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005;26(22):2463–2471. https://doi.org/10.1093/eurheartj/ehi426Ye J, Cheung A, Yamashita M, Wood D, Peng D. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC Cardiovasc Interv. 2015;8:1735–1744. https://doi.org/10.1016/j.jcin.2015.08.012Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC: endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016;37:2893 –2962. https://doi.org/10.1093/eurheartj/ehw210Butchart EG, Gohlke-Barwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, et al. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005;26(22):2463–2471. https://doi.org/10.1093/eurheartj/ehi426Tsai YC, Phan K, Munkholm-Larsen S, Tian DH, La Meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a metaanalysis. Eur J Cardiothorac Surg. 2015;47:847–.854. https://doi.org/10.1093/ejcts/ezu291Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC: endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016;37:2893 –2962. https://doi.org/10.1093/eurheartj/ehw210Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC: endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016;37:2893 –2962. https://doi.org/10.1093/eurheartj/ehw210Tsai YC, Phan K, Munkholm-Larsen S, Tian DH, La Meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a metaanalysis. Eur J Cardiothorac Surg. 2015;47:847–.854. https://doi.org/10.1093/ejcts/ezu291Tsai YC, Phan K, Munkholm-Larsen S, Tian DH, La Meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a metaanalysis. Eur J Cardiothorac Surg. 2015;47:847–.854. https://doi.org/10.1093/ejcts/ezu291
The authors declare that there are no conflicts of interest present.